• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail

  • Print
  • Share
  • E-mail
Pediatric Labeling Date:  02/01/2006
Trade Name:  Clarinex-D 12 Hour Extended Release Tablets
Generic Name or Proper Name (*):  desloratadine/pseudoephedrine
Indications Studied:  Relief of nasal and non-nasal symptoms of seasonal allergic rhinitis in children 12 years of age and older
Label Changes Summary:  * Approval based on two safety and effectiveness studies in patients down to 12 years of age * Not an appropriate dosage form for use in pediatric patients below 12 years of age. * Studies waived in children < 12 years of age * New dosing regimen
Product Labeling:  Labeling  Opens a new window
Sponsor:  Schering
Therapeutic Category:  Antihistamine